Biologic agents in rheumatology: Safety considerations

被引：5

作者：

Lee, Susan J. ^{[1
]}

Kavanaugh, Arthur ^{[1
]}

机构：

[1] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, Ctr Innovat Therapy, San Diego, CA 92103 USA

来源：

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2006年 / 32卷

关键词：

D O I：

10.1016/S0889-857X(07)70003-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：3 / 10

页数：8

共 50 条

[1] Immunogenicity of biologic agents in rheumatology
Vibeke Strand
Joao Goncalves
John D. Isaacs
Nature Reviews Rheumatology, 2021, 17 : 81 - 97
[2] Immunogenicity of biologic agents in rheumatology
Strand, Vibeke
Goncalves, Joao
Isaacs, John D.
NATURE REVIEWS RHEUMATOLOGY, 2021, 17 (02) : 81 - 97
[3] Biologic agents in rheumatology: Act II
Kavanaugh, A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (03) : S2 - S4
[4] PATIENTS' CONCERNS ABOUT BIOLOGIC AGENTS IN RHEUMATOLOGY
Pehlivan, Y.
Pehlivan, S.
Orucoglu, N.
Dalkilic, E.
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 492 - 493
[5] At the horizon of innovative therapy in rheumatology: new biologic agents
Finckh, Axel
Gabay, Cem
CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (03) : 269 - 275
[6] APPLICATION OF BIOLOGIC AGENTS IN RHEUMATOLOGY ATA CENTRAL HOSPITAL UNIT
Segil, J.
Cabello, E.
Rolando, T.
Salinas, A.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S172 - S172
[7] ARE THERE SPECIAL CONSIDERATIONS RELEVANT TO TRIALS OF BIOLOGIC AGENTS
STRAND, V
JOURNAL OF RHEUMATOLOGY, 1994, 21 : 41 - 45
[8] Antibodies against biologic agents (ADAb) in a real life rheumatology cohort: immunogenicity is not similar among all the biologic agents
Berner, J.
Perreau, M.
Aubry-Rozier, B.
So, A.
Zufferey, P.
SWISS MEDICAL WEEKLY, 2014, 144 : 5S - 6S
[9] ARE THERE SPECIAL CONSIDERATIONS RELEVANT TO TRIALS OF BIOLOGIC AGENTS - COMMENT
HUBSCHER, O
JOURNAL OF RHEUMATOLOGY, 1994, 21 : 48 - 48
[10] ARE THERE SPECIAL CONSIDERATIONS RELEVANT TO TRIALS OF BIOLOGIC AGENTS - COMMENT
WOODCOCK, J
JOURNAL OF RHEUMATOLOGY, 1994, 21 : 49 - 49

← 1 2 3 4 5 →